Evidence suggests that pemafibrate can reduce the expression of the cell adhesion molecule VCAM-1 and favorably modulate inflammation- and fibrosis-related genes in a mouse model of NASH (STAM), highlighting its potential protective role against inflammation and fibrosis in this context [312]. The gene discussed is VCAM1; the disease is metabolic dysfunction-associated steatohepatitis.